| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates
|
Fritsche, Thomas R.
|
|
2005
|
52 |
3 |
p. 209-213
5 p.
|
artikel
|
| 2 |
Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline
|
Peterson, Lance R.
|
|
2005
|
52 |
3 |
p. 163-164
2 p.
|
artikel
|
| 3 |
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit
|
Sader, Helio S.
|
|
2005
|
52 |
3 |
p. 203-208
6 p.
|
artikel
|
| 4 |
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia
|
Fritsche, Thomas R.
|
|
2005
|
52 |
3 |
p. 187-193
7 p.
|
artikel
|
| 5 |
Comparative in vitro activities of daptomycin, linezolid, and quinupristin/dalfopristin against Gram-positive bacterial isolates from a large cancer center
|
Smith, Patrick F.
|
|
2005
|
52 |
3 |
p. 255-259
5 p.
|
artikel
|
| 6 |
In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)
|
Hoban, Daryl J.
|
|
2005
|
52 |
3 |
p. 215-227
13 p.
|
artikel
|
| 7 |
In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004)
|
Bouchillon, Samuel K.
|
|
2005
|
52 |
3 |
p. 173-179
7 p.
|
artikel
|
| 8 |
In vitro nonspecific mitogenic response of T-cell subsets in acute and chronic brucellosis
|
Kinikli, Sami
|
|
2005
|
52 |
3 |
p. 229-233
5 p.
|
artikel
|
| 9 |
Pharmacokinetic/pharmacodynamic profile for tigecycline—a new glycylcycline antimicrobial agent
|
Meagher, Alison K.
|
|
2005
|
52 |
3 |
p. 165-171
7 p.
|
artikel
|
| 10 |
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000–2004)
|
Fritsche, Thomas R.
|
|
2005
|
52 |
3 |
p. 195-201
7 p.
|
artikel
|
| 11 |
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: Results from the SENTRY Antimicrobial Surveillance Program (1998–2003)
|
Sader, Helio S.
|
|
2005
|
52 |
3 |
p. 265-273
9 p.
|
artikel
|
| 12 |
Reduction in turnaround time for laboratory diagnosis of pulmonary tuberculosis by routine use of a nucleic acid amplification test
|
Moore, Douglas F.
|
|
2005
|
52 |
3 |
p. 247-254
8 p.
|
artikel
|
| 13 |
Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 β-lactams: adjustments of breakpoints for strains producing extended spectrum β-lactamases
|
Jones, Ronald N.
|
|
2005
|
52 |
3 |
p. 235-246
12 p.
|
artikel
|
| 14 |
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents
|
Sader, Helio S.
|
|
2005
|
52 |
3 |
p. 181-186
6 p.
|
artikel
|
| 15 |
Trends in nalidixic acid resistance in nontyphoidal Salmonella isolated from 1999 to 2002: decreased susceptibility to 6 fluoroquinolones
|
Rodriguez-Avial, Iciar
|
|
2005
|
52 |
3 |
p. 261-264
4 p.
|
artikel
|
Tijdschrift beschrijving